Kathleen J. Propert - Concepedia

Author

Kathleen J. Propert

Also Known As

Gaurnier-Hausser, Anita, K J Propert, K Propert, K. J. Propert, K. Propert, K.J. PROPERT, K.J. Propert, KATHLEEN J. PROPERT, KATHLEEN JOY PROPERT, Kathleen J Propert

172

Publications

13.6K

Citations

H-Index

228

Concepts

All Affiliations

University of Pennsylvania National Institute of Diabetes and Digestive and Kidney Diseases Children's Hospital of Philadelphia University of Maryland, Baltimore Harvard University

About

Kathleen J. Propert is an author at University of Pennsylvania specializing in medicine, health sciences, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	52	5.1K
2	Health Sciences	17	19	1.4K
3	Public Health	9	9	437
4	Engineering	1	1	178
5	Nursing	1	1	59

Kathleen J. Propert

119

Publications

13.3K

Citations

H-Index

Page 1

	Year	Citations
A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer Robert O. Dillman, Stephen L. Seagren, Kathleen J. Propert, New England Journal of Medicine	1990	1.2K
Chemotherapy of Advanced Hodgkin's Disease with MOPP, ABVD, or MOPP Alternating with ABVD George P. Canellos, James R. Anderson, Kathleen J. Propert, New England Journal of Medicine	1992	1.2K
Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study Marina Cuchel, Emma A. Meagher, Hendrik du Toit Theron, The Lancet Metabolic SyndromeLipid DisorderHomozygous Familial HypercholesterolaemiaCardiovascular DiseaseMedicine	2012	728
Immune responses to adenovirus and adeno-associated virus in humans Narendra Chirmule, Kathleen J. Propert, Susan Magosin, Gene Therapy Adeno-associated VirusViral PathogenesisImmunologyAntiviral ResponseVirology	1999	677
Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. Scott Saxman, Kathleen J. Propert, Lawrence H. Einhorn, Journal of Clinical Oncology	1997	496
Chemotherapy with or without Radiation Therapy in Limited Small-Cell Carcinoma of the Lung Michael C. Perry, Walter L. Eaton, Kathleen J. Propert, New England Journal of Medicine Initial RadiotherapyRadiation MedicineRadiation TherapyMedicineToxic Effects	1987	489
A Pilot Study of <i>In Vivo</i> Liver-Directed Gene Transfer with an Adenoviral Vector in Partial Ornithine Transcarbamylase Deficiency Steven E. Raper, Marc Yudkoff, Narendra Chirmule, Human Gene Therapy	2002	350
Prognostic factors in neuroblastoma Audrey E. Evans, Giulio J. D’Angio, Kathleen J. Propert, Cancer Prognostic FactorsPathologyRecursive Partitioning ApproachGliomaNeuro-oncology	1987	320
Phase III Study of Interferon Alfa-NL as Adjuvant Treatment for Resectable Renal Cell Carcinoma: An Eastern Cooperative Oncology Group/Intergroup Trial Edward M. Messing, Judith Manola, George Wilding, Journal of Clinical Oncology	2003	306
A Pilot Clinical Trial of Oral Pentosan Polysulfate And Oral Hydroxyzine in Patients With Interstitial Cystitis Grannum R. Sant, Kathleen J. Propert, Philip M. Hanno, The Journal of Urology	2003	276

Page 1